Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation Factor

Patent No. EP2256135 (titled "Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation Factor") was filed by CSL Behring on Jun 14, 2007. The application was issued on Mar 13, 2019.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
BIOVERATIV THERAPEUTICS	Dec 13, 2019	ZWICKER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Jul 22, 2022
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Jul 19, 2022
Termination of the opposition proceedings with maintenance of patent
Apr 7, 2022
Decision to discontinue the opposition proceedings
Apr 5, 2022
Notification concerning the date of oral proceedings
Apr 1, 2022
Brief communication - Opposition proceedings
Apr 1, 2022
Brief communication - Opposition proceedings
Mar 28, 2022
(Electronic) Receipt
Mar 28, 2022
Withdrawal of an opposition
Aug 13, 2021
Communication of amended entries concerning the representative
Aug 5, 2021
Letter accompanying subsequently filed items
Aug 5, 2021
Submission concerning change of applicant's representative
Jul 27, 2021
(Electronic) Receipt
Jul 27, 2021
Advice of delivery
Jul 27, 2021
Letter accompanying subsequently filed items
Jul 14, 2021
Communication about missing advice of delivery
Jun 17, 2021
Advice of delivery
Jun 8, 2021
Annex to the communication - opposition
Jun 8, 2021
Information concerning oral proceedings
Jun 8, 2021
Summons to attend oral proceedings
Jun 8, 2021
Summons to attend oral proceedings
Jun 8, 2021
Transmittal of decision / summons - opposition
Jun 8, 2021
Transmittal of decision / summons - opposition
Feb 18, 2021
Brief communication - Opposition proceedings
Feb 18, 2021
Brief communication - Opposition proceedings
Feb 12, 2021
(Electronic) Receipt
Feb 12, 2021
(Electronic) Receipt
Feb 12, 2021
Citation in opposition procedure - 009
Feb 12, 2021
Citation in opposition procedure - 010
Feb 12, 2021
Citation in opposition procedure - 011
Feb 12, 2021
Citation in opposition procedure - 012
Feb 12, 2021
Consolidated list of cited opposition documents
Feb 12, 2021
Letter accompanying subsequently filed items
Feb 12, 2021
Letter accompanying subsequently filed items
Feb 12, 2021
Reply to an examination report in opposition proceedings
Feb 12, 2021
Reply to an examination report in opposition proceedings
Jan 12, 2021
Brief communication - Opposition proceedings
Dec 16, 2020
(Electronic) Receipt
Dec 16, 2020
Letter accompanying subsequently filed items
Dec 16, 2020
Reply to an examination report in opposition proceedings
Oct 2, 2020
Annex to the communication - opposition
Oct 2, 2020
Communication inviting the parties to file observations
Oct 2, 2020
Internal form - Opposition/addressees
Sep 23, 2020
Communication inviting the parties to file observations
Jul 8, 2020
Brief communication - Opposition proceedings
Jul 1, 2020
(Electronic) Receipt
Jul 1, 2020
Auxiliary request during Opposition procedure
Jul 1, 2020
Auxiliary request during Opposition procedure
Jul 1, 2020
Auxiliary request during Opposition procedure
Jul 1, 2020
Auxiliary request during Opposition procedure
Jul 1, 2020
Auxiliary request during Opposition procedure
Jul 1, 2020
Auxiliary request during Opposition procedure - 01
Jul 1, 2020
Auxiliary request during Opposition procedure - 02
Jul 1, 2020
Auxiliary request during Opposition procedure - 03
Jul 1, 2020
Auxiliary request during Opposition procedure - 04
Jul 1, 2020
Auxiliary request during Opposition procedure - 05
Jul 1, 2020
Citation in opposition procedure - 007
Jul 1, 2020
Citation in opposition procedure - 008
Jul 1, 2020
Letter accompanying subsequently filed items
Jul 1, 2020
Letter regarding the opposition procedure (no time limit)
Jul 1, 2020
Reply of the patent proprietor to the notice(s) of opposition
May 4, 2020
Brief communication - Opposition proceedings
May 4, 2020
Brief communication - Opposition proceedings
Apr 29, 2020
Brief communication - Opposition proceedings
Apr 22, 2020
(Electronic) Receipt
Apr 22, 2020
Letter accompanying subsequently filed items
Apr 22, 2020
Letter regarding the opposition procedure (no time limit)
Apr 14, 2020
Brief communication - Opposition proceedings
Apr 14, 2020
Grant of extension of time limit (opposition procedure)
Mar 31, 2020
(Electronic) Receipt
Mar 31, 2020
Letter accompanying subsequently filed items
Mar 31, 2020
Request for extension of time limit
Jan 7, 2020
Communication of a notice of opposition and request to file observations
Jan 7, 2020
Notice of further oppositions to opponent(s)
Jan 3, 2020
Communication of a notice of opposition - first information to patent proprietor
Dec 13, 2019
(Electronic) Receipt
Dec 13, 2019
Citation in opposition procedure - 001
Dec 13, 2019
Citation in opposition procedure - 002
Dec 13, 2019
Citation in opposition procedure - 003
Dec 13, 2019
Citation in opposition procedure - 004
Dec 13, 2019
Citation in opposition procedure - 005
Dec 13, 2019
Citation in opposition procedure - 006
Dec 13, 2019
Consolidated list of cited opposition documents
Dec 13, 2019
Notice of opposition
Dec 13, 2019
Notice of opposition
Mar 25, 2019
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Feb 14, 2019
Decision to grant a European patent
Jan 31, 2019
(Electronic) Receipt
Jan 31, 2019
Filing of the translations of the claims
Jan 31, 2019
French translation of claims
Jan 31, 2019
German translation of the claims
Jan 31, 2019
Letter accompanying subsequently filed items
Jan 8, 2019
Bibliographic data of the European patent application
Jan 8, 2019
Communication about intention to grant a European patent
Jan 8, 2019
Intention to grant (signatures)
Jan 8, 2019
Text intended for grant (clean copy)
Jan 8, 2019
Text intended for grant (sequence listing)
Jan 8, 2019
Text intended for grant (version for approval)
Nov 20, 2018
(Electronic) Receipt
Nov 20, 2018
Amended claims with annotations
Nov 20, 2018
Amended description with annotations
Nov 20, 2018
Claims
Nov 20, 2018
Description
Nov 20, 2018
Letter accompanying subsequently filed items
Nov 20, 2018
Reply to communication from the Examining Division
Aug 13, 2018
Annex to the communication
Aug 13, 2018
Communication from the Examining Division
Jun 29, 2018
Acknowledgement of receipt of third party observations
Jun 29, 2018
Transmittal of third party observations to applicant
Jun 13, 2018
Observations by third parties
Jun 13, 2018
Observations by third parties
Apr 20, 2018
Bibliographic data of the European patent application
Apr 20, 2018
Communication about intention to grant a European patent
Apr 20, 2018
Intention to grant (signatures)
Apr 20, 2018
Text intended for grant (clean copy)
Apr 20, 2018
Text intended for grant (sequence listing)
Apr 20, 2018
Text intended for grant (version for approval)
Nov 16, 2017
(Electronic) Receipt
Nov 16, 2017
Amended claims with annotations
Nov 16, 2017
Amended description with annotations
Nov 16, 2017
Claims
Nov 16, 2017
Description
Nov 16, 2017
Letter accompanying subsequently filed items
Nov 16, 2017
Reply to communication from the Examining Division
Jul 31, 2017
Communication of amended entries concerning the representative
Jul 24, 2017
Submission concerning change of applicant's representative
Jul 6, 2017
Annex to the communication
Jul 6, 2017
Communication from the Examining Division
Apr 1, 2016
(Electronic) Receipt
Apr 1, 2016
Amended claims with annotations
Apr 1, 2016
Claims
Apr 1, 2016
Letter accompanying subsequently filed items
Apr 1, 2016
Reply to communication from the Examining Division
Jan 8, 2016
Grant of extension of time limit (examination procedure)
Dec 21, 2015
(Electronic) Receipt
Dec 21, 2015
Letter accompanying subsequently filed items
Dec 21, 2015
Request for extension of time limit to communication from the Examining Division
Oct 29, 2015
Grant of extension of time limit (examination procedure)
Oct 23, 2015
(Electronic) Receipt
Oct 23, 2015
Letter accompanying subsequently filed items
Oct 23, 2015
Request for extension of time limit to communication from the Examining Division
Jul 21, 2015
Communication confirming withdrawal from representation
Jul 21, 2015
Communication of amended entries concerning the representative
Jul 7, 2015
(Electronic) Receipt
Jul 7, 2015
Letter accompanying subsequently filed items
Jul 7, 2015
Submission concerning change of applicant's representative
Jun 22, 2015
Annex to the communication
Jun 22, 2015
Communication from the Examining Division
Nov 14, 2013
(Electronic) Receipt
Nov 14, 2013
Amended claims with annotations
Nov 14, 2013
Claims
Nov 14, 2013
Letter accompanying subsequently filed items
Nov 14, 2013
Reply to the invitation to remedy deficiencies
Nov 11, 2013
Invitation to confirm documents filed by fax
Nov 5, 2013
Amended claims with annotations
Nov 5, 2013
Claims
Nov 5, 2013
Reply to communication from the Examining Division
Jul 19, 2013
Annex to the communication
Jul 19, 2013
Communication from the Examining Division
Nov 18, 2011
Reply to communication from the Examining Division
Oct 13, 2011
Grant of extension of time limit (examination procedure)
Oct 4, 2011
Request for extension of time limit to communication from the Examining Division
Jul 14, 2011
Annex to the communication
Jul 14, 2011
Communication from the Examining Division
May 26, 2011
Amended claims filed after receipt of (European) search report
May 26, 2011
Amended claims with annotations
May 26, 2011
Amendments received before examination
Dec 6, 2010
Reminder period for payment of examination fee/designation fee and correction of deficiencies in Written Opinion/amendment
Nov 4, 2010
Notification of forthcoming publication
Oct 20, 2010
Refund of fees
Oct 7, 2010
Communication regarding the transmission of the European search report
Oct 7, 2010
European search opinion
Oct 7, 2010
European search report
Aug 23, 2010
Confirmation of receipt of (electronically) transmitted priority document
Jul 5, 2010
Abstract
Jul 5, 2010
Acknowledgement of receipt of electronic submission of the request for grant of a European patent
Jul 5, 2010
Claims
Jul 5, 2010
Description
Jul 5, 2010
Designation of inventor
Jul 5, 2010
Designation of inventor
Jul 5, 2010
Designation of inventor
Jul 5, 2010
Drawings
Jul 5, 2010
Request for grant of a European patent
Jul 5, 2010
Sequence listing
Jan 10, 2008
Priority document (electronically transmitted)
Jan 10, 2008
Priority document (electronically transmitted)

EP2256135

CSL BEHRING

Application Number: EP10168453A
Filing Date: Jun 14, 2007
Status: Granted And Under Opposition; Feb 8, 2019
Publication Date: Mar 13, 2019
External Links: Slate, Register , Google Patents

IP Verse

Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation Factor

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2256135